CN105012578A - Traditional Chinese medicine composition for treating allergic rhinitis - Google Patents
Traditional Chinese medicine composition for treating allergic rhinitis Download PDFInfo
- Publication number
- CN105012578A CN105012578A CN201510397454.1A CN201510397454A CN105012578A CN 105012578 A CN105012578 A CN 105012578A CN 201510397454 A CN201510397454 A CN 201510397454A CN 105012578 A CN105012578 A CN 105012578A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- medicine composition
- chinese medicine
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating allergic rhinitis. Raw materials of the traditional Chinese medicine composition contain, by weight, 4-6 parts of semen cuscutae, 3-5 parts of cimicifuga foetida, 2-4 parts of Chinese angelica, 7-9 parts of Saposhnikovia divaricata, 5-8 parts of Chinese magnoliavine, 2-4 parts of Asarum Herb, 4-5 parts of radix aconiti lateralis preparata, 2-4 parts of bighead atractylodes rhizome, 6-8 parts of xanthium, 4-5 parts of clove, 2-4 parts of Agastache rugosus, 1-3 parts of Fructus Arctii, 6-8 parts of phellodendron, 4-5 parts of Small Centipeda Herb, 2-4 parts of aloe, 1-3 parts of rehmannia root, 5-8 parts of schizonepeta spike, 4-5 parts of yerbadetajo herb, 2-4 parts of Solanum khasianum C. B. Clarke, 1-3 parts of Anemone tomentosa and 2-4 parts of greyhair raspberry root and leaf. The traditional Chinese medicine composition has main effects of invigorating spleen for benefiting lung and dispelling wind and clearing the nasal passage. Chinese angelica, Saposhnikovia divaricata, Chinese magnoliavine, Asarum Herb, radix aconiti lateralis preparata and bighead atractylodes rhizome in the formula have effects of invigorating spleen and supplementing Qi and are monarch drugs. Agastache rugosus, Fructus Arctii, phellodendron, Small Centipeda Herb, aloe and rehmannia root have effects of dispelling wind and relieving stuffy nose and are ministerial drugs. With the combination of the above drugs, the traditional Chinese medicine composition has effects of dispelling wind and cold, relieving stuffy nose with drugs of pungent taste and warm nature, adjusting Qi and blood, activating stagnancy and dispersing blood stasis, warming lung and tonifying Qi and dispelling the wind to relieve stuffy nose. In addition, the traditional Chinese medicine composition has wide medicinal herbs resources, is harmless to human body and has a remarkable effect of treating allergic rhinitis.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition for the treatment of of allergic rhinitis, belong to the field of Chinese medicines.
Background technology
Allergic rhinitis is also known as allergic rhinitis, it is the allergic disease of nasal membrane, separately there is a type to be brought out by nonspecific stimulation, participate in without specific allergen, be not immunoreaction process, but clinical manifestation is similar to above-mentioned amphitypy allergic rhinitis, claim vasomotor rhinitis or claim neural reflex rhinitis, stimulation can from external, or ex vivo, therefore namely have people to regard as be allergic rhinitis, but because there is not antigen-antibody reaction in body, so desensitization therapy, hormone or immunotherapy are all invalid; Allergic rhinitis main manifestations is rhinocnesmus, sneeze, nasal obstruction, watery nasal discharge, and some patients is also with discomforts such as dry nasal cavity, headache, ophthalmic pruritus, and the sickness rate of this disease is higher, about has the people of about 20% to suffer from allergic rhinitis; The Chinese medicine and western medicine being used for the treatment of allergic rhinitis at present clinically has a lot, and these medicines all have certain curative effect to allergic rhinitis, but also there are some problems, and as some drug effect is slow, effect is not fairly obvious, and Time of Administration is long, and curative effect is unstable etc.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine composition for the treatment of of allergic rhinitis.
The present invention adopts following technical scheme:
The Chinese medicine composition for the treatment of of allergic rhinitis, the weight portion of its constitutive material is: Semen Cuscutae 4-6, Rhizoma Cimicifugae 3-5, Radix Angelicae Sinensis 2-4, Radix Saposhnikoviae 7-9, Fructus Schisandrae Chinensis 5-8, Herba Asari 2-4, Radix Aconiti Lateralis Preparata 4-5, Rhizoma Atractylodis Macrocephalae 2-4, Fructus Xanthii 6-8, Flos Caryophylli 4-5, Herba Pogostemonis 2-4, Fructus Arctii 1-3, Cortex Phellodendri 6-8, Herba Centipedae 4-5, Aloe 2-4, Radix Rehmanniae 1-3, Herba Schizonepetae 5-8, Herba Ecliptae 4-5, Radix Euonymi Wilsonii 2-4, Radix Anemones Tomentosae 1-3 and Radix seu Folium Rubi Irenaei 2-4.
The Chinese medicine composition for the treatment of of allergic rhinitis, the weight portion of its constitutive material is: Semen Cuscutae 5, Rhizoma Cimicifugae 4, Radix Angelicae Sinensis 3, Radix Saposhnikoviae 8, Fructus Schisandrae Chinensis 6, Herba Asari 3, Radix Aconiti Lateralis Preparata 4.5, the Rhizoma Atractylodis Macrocephalae 3, Fructus Xanthii 7, Flos Caryophylli 4.5, Herba Pogostemonis 3, Fructus Arctii 2, Cortex Phellodendri 7, Herba Centipedae 4.5, Aloe 3, Radix Rehmanniae 2, Herba Schizonepetae 6, Herba Ecliptae 4.5, Radix Euonymi Wilsonii 3, Radix Anemones Tomentosae 2 and Radix seu Folium Rubi Irenaei 3.
Radix Euonymi Wilsonii is the leaf of plant of Solanaceae Solanum aculeatissimum Jacq.; Radix Anemones Tomentosae is the root of the large fire weed of ranunculaceae plant; Radix seu Folium Rubi Irenaei is root, the leaf of rosaceous plant Radix seu Folium Rubi Irenaei.
Consumption and usage: take Chinese medicine composition of the present invention, every day potion, within 10 days, be a course for the treatment of, general 2-3 can cure a course for the treatment of.
Beneficial effect of the present invention:
The present invention is with invigorating the spleen to benefit the lung, and loose wind profit key is main, Radix Angelicae Sinensis, Radix Saposhnikoviae, Fructus Schisandrae Chinensis, Herba Asari, Radix Aconiti Lateralis Preparata, Rhizoma Atractylodis Macrocephalae invigorating the spleen and benefiting QI in side, and be monarch drug, Herba Pogostemonis, Fructus Arctii, Cortex Phellodendri, Herba Centipedae, Aloe, Radix Rehmanniae expelling pathogenic wind and restoring the functions of orifices in face are ministerial drug; All medicines share, and have expelling wind and cold, and Xin Wen is sensible, regulate vim and vigour, the stagnant blood stasis dispelling of row, warming the lung and benefiting QI, expelling pathogenic wind and restoring the functions of orifices in face, and medicine source of the present invention is extensive, harmless, treatment of allergic rhinitis Be very effective.
Detailed description of the invention
Embodiment 1: the Chinese medicine composition for the treatment of of allergic rhinitis, the weight portion (g) of its constitutive material is: Semen Cuscutae 5, Rhizoma Cimicifugae 4, Radix Angelicae Sinensis 3, Radix Saposhnikoviae 8, Fructus Schisandrae Chinensis 6, Herba Asari 3, Radix Aconiti Lateralis Preparata 4.5, the Rhizoma Atractylodis Macrocephalae 3, Fructus Xanthii 7, Flos Caryophylli 4.5, Herba Pogostemonis 3, Fructus Arctii 2, Cortex Phellodendri 7, Herba Centipedae 4.5, Aloe 3, Radix Rehmanniae 2, Herba Schizonepetae 6, Herba Ecliptae 4.5, Radix Euonymi Wilsonii 3, Radix Anemones Tomentosae 2 and Radix seu Folium Rubi Irenaei 3.
Consumption and usage: take Chinese medicine composition of the present invention, every day potion, within 10 days, be a course for the treatment of, general 2-3 can cure a course for the treatment of.
Model case:
Case 1: money, man, 19 years old, suffer from more than three years of allergic rhinitis, recurrent exerbation, have a strong impact on the school work of patient, normal with symptoms such as paroxysmal sneeze, snivel, nasal obstruction, rhinocnesmus, after take Chinese medicine composition of the present invention, every day potion, after taking more than ten skies, sneeze, thin nasal discharge, nasal obstruction, rhinocnesmus symptom obviously alleviate, continue to take a course for the treatment of with consolidate curative effect, transference cure, cure.
Case 2: Zhang, man, 37 years old, suffers from allergic rhinitis, recurrent exerbation, the every day of paroxysmal outbreak for several times, and paroxysmal sneeze, clear water sample nasal mucus, nasal obstruction and rhinocnesmus during outbreak, with hyposmia; Multi-treatment is invalid, after take Chinese medicine composition of the present invention, every day potion, after taking five doses, symptom obviously alleviates, and continues to take two courses for the treatment of, and all diseases disappear entirely, cure.
Case 3: appoint certain, female, 48 years old, suffers from allergic rhinitis, with symptoms such as nasal obstruction, rhinorrhea, sneeze, every morning shows effect, and multi-treatment is invalid, after take Chinese medicine composition of the present invention, every day potion, after serveing on a course for the treatment of, nasal obstruction, rhinorrhea, sneeze transference cure, after continue to take a course for the treatment of, do not recur so far.
Claims (2)
1. a Chinese medicine composition for treatment of allergic rhinitis, is characterized in that the weight portion of its constitutive material is: Semen Cuscutae 4-6, Rhizoma Cimicifugae 3-5, Radix Angelicae Sinensis 2-4, Radix Saposhnikoviae 7-9, Fructus Schisandrae Chinensis 5-8, Herba Asari 2-4, Radix Aconiti Lateralis Preparata 4-5, Rhizoma Atractylodis Macrocephalae 2-4, Fructus Xanthii 6-8, Flos Caryophylli 4-5, Herba Pogostemonis 2-4, Fructus Arctii 1-3, Cortex Phellodendri 6-8, Herba Centipedae 4-5, Aloe 2-4, Radix Rehmanniae 1-3, Herba Schizonepetae 5-8, Herba Ecliptae 4-5, Radix Euonymi Wilsonii 2-4, Radix Anemones Tomentosae 1-3 and Radix seu Folium Rubi Irenaei 2-4.
2. the Chinese medicine composition for the treatment of of allergic rhinitis according to claim 1, is characterized in that the weight portion of its constitutive material is: Semen Cuscutae 5, Rhizoma Cimicifugae 4, Radix Angelicae Sinensis 3, Radix Saposhnikoviae 8, Fructus Schisandrae Chinensis 6, Herba Asari 3, Radix Aconiti Lateralis Preparata 4.5, the Rhizoma Atractylodis Macrocephalae 3, Fructus Xanthii 7, Flos Caryophylli 4.5, Herba Pogostemonis 3, Fructus Arctii 2, Cortex Phellodendri 7, Herba Centipedae 4.5, Aloe 3, Radix Rehmanniae 2, Herba Schizonepetae 6, Herba Ecliptae 4.5, Radix Euonymi Wilsonii 3, Radix Anemones Tomentosae 2 and Radix seu Folium Rubi Irenaei 3.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510397454.1A CN105012578A (en) | 2015-07-09 | 2015-07-09 | Traditional Chinese medicine composition for treating allergic rhinitis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510397454.1A CN105012578A (en) | 2015-07-09 | 2015-07-09 | Traditional Chinese medicine composition for treating allergic rhinitis |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105012578A true CN105012578A (en) | 2015-11-04 |
Family
ID=54403123
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510397454.1A Pending CN105012578A (en) | 2015-07-09 | 2015-07-09 | Traditional Chinese medicine composition for treating allergic rhinitis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105012578A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105250798A (en) * | 2015-11-26 | 2016-01-20 | 王平平 | Drug for treating rhinitis chronic |
CN105395755A (en) * | 2015-11-30 | 2016-03-16 | 马瑞 | Internal medicine for treating allergic rhinitis |
CN105687557A (en) * | 2016-01-26 | 2016-06-22 | 刘汉业 | Herbal rhinitis ointment and production method of herbal rhinitis ointment |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101700280A (en) * | 2009-11-11 | 2010-05-05 | 丁常燕 | Traditional Chinese medicine for treating allergic rhinitis |
-
2015
- 2015-07-09 CN CN201510397454.1A patent/CN105012578A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101700280A (en) * | 2009-11-11 | 2010-05-05 | 丁常燕 | Traditional Chinese medicine for treating allergic rhinitis |
Non-Patent Citations (2)
Title |
---|
胡桂明等: "中药熏鼻法治疗鼻炎500例临床观察", 《职业与健康》 * |
谷志平: "中药治疗过敏性鼻炎34例报道", 《河北中医》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105250798A (en) * | 2015-11-26 | 2016-01-20 | 王平平 | Drug for treating rhinitis chronic |
CN105395755A (en) * | 2015-11-30 | 2016-03-16 | 马瑞 | Internal medicine for treating allergic rhinitis |
CN105687557A (en) * | 2016-01-26 | 2016-06-22 | 刘汉业 | Herbal rhinitis ointment and production method of herbal rhinitis ointment |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103356756B (en) | Traditional Chinese medicine composition for treating allergic rhinitis | |
CN102670961B (en) | Traditional Chinese medicine for treating middle and old aged habitual constipation | |
CN100366279C (en) | Method for preparing traditional Chinese medicine to treat apoplexia hemiplegia and said medicine | |
CN105012578A (en) | Traditional Chinese medicine composition for treating allergic rhinitis | |
CN104107289A (en) | Traditional Chinese medicinal composition for treating orthopedic diseases | |
CN103463254B (en) | Traditional Chinese medicine composition for treating allergic rhinitis | |
CN103784804A (en) | Pharmaceutical composition for treating benign prostatic hyperplasia | |
CN103393999A (en) | Anti-inflammatory resolutive liquid medicine for promoting blood circulation to arrest pain | |
CN103356968A (en) | Traditional Chinese medicine composition for treating endometriosis | |
CN102885904A (en) | Traditional Chinese medicinal watered pill preparation for treating rhinitis | |
CN103721082A (en) | Traditional Chinese medicinal composition for treating scapulohumeral periarthritis | |
CN107913377A (en) | It is a kind of treat rheumatic disease harvest sub- wine and preparation method thereof | |
CN104056177A (en) | Traditional Chinese medicine composition for treating otitis media | |
CN103705659A (en) | Traditional Chinese medicine composition for treating rhinitis | |
CN1990010A (en) | Chinese medicinal herb liquid | |
CN103690621B (en) | Traditional Chinese medicine decoction for treating scapulohumeral periarthritis | |
CN104027590A (en) | Traditional Chinese medicine decoction for treating rheumatism pain | |
CN103566115A (en) | Traditional Chinese medicine composition for treating arthralgia and myalgia | |
CN101934010B (en) | Plaster for treating rheumatic diseases | |
CN105816602A (en) | Traditional Chinese medicine composition for treating chronic pain in waist and lower extremities | |
CN104815132A (en) | External lotion for treating low back and leg pain and preparation method | |
CN105250812A (en) | Chinese herb composition for treating shoulder periarthritis | |
CN103948764A (en) | Traditional Chinese medicine for treating edema during menstruation | |
CN104324190A (en) | External traditional Chinese medicine for treating mouse hand and preparation method thereof | |
CN104127559A (en) | Medicinal liquor for treating rheumatic arthritis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20151104 |
|
RJ01 | Rejection of invention patent application after publication |